Blood Cancer Journal - Table of Contents alert Volume 4 April 2014

If you are unable to see the message below, click here to view.

Advertisement BD FACSCanto™ has 10-color capability.  Reliable performance, accuracy, and ease of use make the latest BD FACSCanto System a perfect 10 for today's busy clinical labs. Learn how you can achieve dependable outcomes while speeding workflow and reducing training requirements with clinical multi-color flow cytometry systems from BD Biosciences. bdbiosciences.com/go/canto   TABLE OF CONTENTS Volume 4, April 2014 In this issue Reviews Original Article Letters to the Editor Corrigenda Sign up for e-alerts Web feed Advertisement Read some of the most cited articles from Blood Cancer Journal  Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules   Hairy cell leukemia: short review, today's recommendations and outlook    Reviews Top The evolution of clinical trials for infant acute lymphoblastic leukemia R S Kotecha, N G Gottardo, U R Kees and C H Cole Blood Cancer J 2014 4: e200; 10.1038/bcj.2014.17 Abstract | Full Text The emerging role of Twist proteins in hematopoietic cells and hematological malignancies N Merindol, A Riquet, V Szablewski, J-F Eliaou, A Puisieux and N Bonnefoy Blood Cancer J 2014 4: e206; 10.1038/bcj.2014.22 Abstract | Full Text Original Article Top Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region K Sakamoto, T Imamura, M Yano, H Yoshida, A Fujiki, Y Hirashima and H Hosoi Blood Cancer J 2014 4: e205; 10.1038/bcj.2014.25 Abstract | Full Text Letters to the Editor Top Cytotoxic response of human regulatory T cells upon T-cell receptor-mediated activation: a matter of purity S Koristka, M Cartellieri, C Arndt, A Feldmann, K Töpfer, I Michalk, A Temme, G Ehninger and M Bachmann Blood Cancer J 2014 4: e199; 10.1038/bcj.2014.20 Full Text The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial A Masurekar, C Fong, A Hussein, T Revesz, P M Hoogerbrugge, S Love, C Ciria, C Parker, S Krishnan and V Saha Blood Cancer J 2014 4: e203; 10.1038/bcj.2014.26 Full Text Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination I Sahin, M Moschetta, Y Mishima, S V Glavey, B Tsang, F Azab, S Manier, Y Zhang, P Maiso, A Sacco, A K Azab, A M Roccaro and I M Ghobrial Blood Cancer J 2014 4: e204; 10.1038/bcj.2014.24 Full Text Corrigenda Top Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity C Batenchuk, F Le Boeuf, L Stubbert, T Falls, H L Atkins, J C Bell and D P Conrad Blood Cancer J 2014 4: e201; 10.1038/bcj.2014.21 Full Text Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma D S Siegel, P Richardson, M Dimopoulos, P Moreau, C Mitsiades, D Weber, J Houp, C Gause, S Vuocolo, J Eid, T Graef and K C Anderson Blood Cancer J 2014 4: e202; 10.1038/bcj.2014.23 Full Text Advertisement Don't miss these recently trending articles from Blood Cancer Journal  Read the articles for FREE  They may bring articles to your attention that you might not have otherwise noticed. We hope you enjoy them.   You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.